Skip to main content
Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
1.910
-0.020 (-1.04%)
Oct 10, 2024, 4:00 PM EDT - Market closed

Stereotaxis Revenue

Stereotaxis had revenue of $4.50M in the quarter ending June 30, 2024, a decrease of -42.72%. This brings the company's revenue in the last twelve months to $23.75M, down -19.14% year-over-year. In the year 2023, Stereotaxis had annual revenue of $26.77M, down -4.89%.

Revenue (ttm)
$23.75M
Revenue Growth
-19.14%
P/S Ratio
6.77
Revenue / Employee
$194,639
Employees
122
Market Cap
164.53M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.77M-1.38M-4.89%
Dec 31, 202228.15M-6.87M-19.63%
Dec 31, 202135.02M8.39M31.51%
Dec 31, 202026.63M-2.27M-7.86%
Dec 31, 201928.90M-444.07K-1.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nevro 426.10M
Lifecore Biomedical 128.44M
CVRx, Inc. 44.39M
Innate Pharma 36.20M
Caribou Biosciences 33.11M
Sangamo Therapeutics 12.28M
Lineage Cell Therapeutics 6.19M
Revenue Rankings

STXS News

More News